|
|||||
|
|
A phase I/II trial of the combination of lenalidomide,thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma |
|
| Authors: | Hans C. Lee Jatin J. Shah Lei Feng Ashley Morphey Ralph J. Johnson Emily T. Wesson Michael L. Wang Raymond Alexanian Sheeba K. Thomas Robert Z. Orlowski Donna M. Weber |
| Affiliation: | 1. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Karyopharm Therapeutics, Newton, Massachusetts;3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas;4. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | |